MCG
EW icon

MACRO Consulting Group’s Edwards Lifesciences EW Stock Holding History

MACRO Consulting Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$233K Buy
+2,250
New +$212K 0.12% 101
2021
Q1 		– Sell
-2,250
Closed -$205K – 105
2020
Q4 		$205K Buy
+2,250
New +$187K 0.12% 102

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

MACRO Consulting Group's EW Position: Q2 2021 in Review

MACRO Consulting Group opened a new position in Edwards Lifesciences (EW) in Q2 2021: 2,250 shares worth $233K. The stake represents 0.12% of the portfolio and ranks #101 among its holdings. This is a return to the name: MACRO Consulting Group previously reported a position in EW as recently as Q4 2020.

MACRO Consulting Group first reported a position in EW in Q4 2020 and has held it in 2 quarters since. 1,186 funds tracked by Wall St. Rank hold EW as of Q2 2021.

  • MACRO Consulting Group held 2,250 shares of Edwards Lifesciences worth $233K as of Q2 2021.
  • Edwards Lifesciences was a new MACRO Consulting Group position in Q2 2021.
  • Edwards Lifesciences made up 0.12% of MACRO Consulting Group's portfolio in Q2 2021, its #101 holding.
  • MACRO Consulting Group first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 2 quarters since.
  • 1,186 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2021.

Based on MACRO Consulting Group's 13F filing for Q2 2021, filed 16 Aug 2021.